Merck (MRK) And Ridgeback Announce Initiation of a Rolling Review by EU Agency for Molnupiravir,

Go back to Merck (MRK) And Ridgeback Announce Initiation of a Rolling Review by EU Agency for Molnupiravir,
Merck & Co. (NYSE: MRK) Delayed: 115.48 +1.61 (1.41%)
Previous Close $113.87    52 Week High $65.46 
Open $113.97    52 Week Low $47.97 
Day High $115.63    P/E 78.56 
Day Low $113.00    EPS $1.47 
Volume 10,467,397